Eric Schadt, PhD

Eric Schadt serves as Chief Scientific Officer of Pathos, an information-driven precision oncology company where he leads the scientific vision for translating vast multi-scale biological data into new cancer therapies. A mathematician and computational biologist by training, Schadt has spent his career pioneering the integration of large-scale genomic data with machine learning to move precision medicine into the standard of care, and he brings that systems-level approach to Pathos's mission of accelerating drug discovery and development.

Before joining Pathos in 2022, Schadt was founding CEO and later Chief R&D Officer of Sema4 (now GeneDx), and he co-founded the nonprofit Sage Bionetworks. Earlier, he held senior scientific roles at Rosetta Inpharmatics, Merck, and Pacific Biosciences. In 2011 he joined the Icahn School of Medicine at Mount Sinai, where he founded the Icahn Institute for Genomics and Multiscale Biology and chaired the Department of Genetics and Genomic Sciences. He continues as Dean for Precision Medicine and Mount Sinai Professor in Predictive Health and Computational Biology, and has authored more than 500 scientific papers.